Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Compare the immunogenicity, reactogenicity & safety of 2 different formulations of GSK Biologicals’ live attenuated human rotavirus (HRV) vaccine given as a two-dose primary vaccination in healthy infants previously uninfected with HRV
Rotavirus Vaccine
104480
NCT00137930
Infections, Rotavirus
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
January 2014

Powered by ideaPoint, Inc.